Human Exposure to the Jet Fuel, JP-8

Aviation Space and Environmental Medicine

Volumn 75, Issue 1, 2004, Pages 49-59

  Tu, Raymond H ^a   Mitchell, Clifford S ^a   Kay, Gary G ^b   Risby, Terence H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Washington Neuropsychological Institute   (United States)

Author keywords

Breath analysis; Exposure assessment; Neurocognitive effects; Renal and liver function

Indexed keywords

ALIPHATIC HYDROCARBON; AROMATIC HYDROCARBON; FUEL;

ADULT; AIR FORCE; ARTICLE; BREATH ANALYSIS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HEALTH HAZARD; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; SAFETY; STANDARD;

ADULT; AVIATION; BREATH TESTS; COGNITION; ENVIRONMENTAL MONITORING; EXHALATION; FEMALE; HUMANS; HYDROCARBONS; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; MAINTENANCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES;

EID: 0348047523     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Allen DG, Riviere JE, Monteiro-Riviere NA. Identification of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels jet A, JP-8, and JP-8 (100). J Biochem Mol Toxicol 2000; 14:231-7.
2. Armbrust Aviation Group. 1998 world jet fuel almanac. Palm Beach Gardens, FL: Armbrust Group; 1998.
3. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993; 48:1034.
4. Baynes RE, Brooks JD, Budsaba K, et al. Mixture effects of JP-8 additives on the dermal disposition of jet fuel components. Toxicol Appl Pharmacol 2001; 175:269-81.
5. Bolla K, Schwartz B, Stewart W, et al. Comparison of neurobehavioral function in workers exposed to a mixture of organic and inorganic lead and in workers exposed to solvents. Am J Indust Med 1995; 27:231-46.
6. Callister JD, King RE, Retzlaff PD. Cognitive assessment of USAF pilot training candidates. Aviat Space Environ Med 1996; 67:1124-9.
7. Kabbur MB, Rogers JV, Gunasekar PG, et al. Effect of JP-8 jet fuel on molecular and histological parameters related to acute skin irritation. Toxicol Appl Pharmacol 2001; 175:83-8.
8. Kanikkannan N, Patel R, Jackson T, et al. Percutaneous absorption and skin irritation of JP-8 (jet fuel). Toxicology 2001; 161:1-11.
9. Kay GG. COGSCREEN: professional manual. Odessa, FL: Psychological Assessment Resources; 1995.
10. Kay GG, Berman B, Mockoviak SH, et al. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood and psychomotor performance. Arch Intern Med 1997; 157:2350-6.
11. Lindstrom AB, Pleil JD. Volatile organic compounds as exposure markers. In: Marczin N, Yacoub MH, eds. Disease markers in exhaled breath. Amsterdam: IOS Press; 2002:105-12.
12. Mapou RL, Kay GG, Rundell JR, Temoshook L. Measuring performance decrements in aviation personnel infected with the human immunodeficiency virus. Aviat Space Environ Med 1993; 64:158-64.
13. McDougal JN, Pollard DL, Weisman W, et al. Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol Sci 2000; 55:247-55.
14. Monteiro-Riviere N, Inman A, Riviere J. Effects of short-term high-dose and low-dose dermal exposure to Jet A, JP-8, and JP-8 + 100 jet fuels. J Appl Toxicol 2001; 21:485-94.
15. National Technical Information Service (NTIS). Toxicological profile for jet fuels (JP-5, and JP-8). Springfiled, VA: NTIS; 1998.
16. Navy Occupational Safety, and Health (NAVOSH) Standards Update Board. Interim recommendations for permissible fuel exposure criteria from the Navy Environmental Health Center. Norfolk, VA: Navy Environmental Health Center Memorandum. Ser 342514: 6261, April 1992:9.
17. Otterbein LE, Mantell LL, Choi AMK. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol 1999; 276: L688-L694.
18. Pleil JD, Smith LB, Zelnick SD. Personal exposure to JP-8 jet fuel vapors and exhaust at air force bases. Environ Health Persp 2000; 108:183-92.
19. Risby TH. Volatile organic compounds as markers. In: Marczin N, Yacoub MH, eds. Disease markers in exhaled breath. Amsterdam: IOS Press; 2002:113-21.
20. Risby TH, Sehnert SS. Clinical application of breath biomarkers of oxidative stress status. Free Rad Biol Med 1999; 27:1182-92.
21. Ritchie G, Still K, Rossi III J, et al. Biological and health effects of exposure to kerosene-based jet fuels and performance additives. J Toxicol Environ. Health B Crit Rev 2003; 6:357-451.
22. Riviere JE, Brooks JD, Monteiro-Riviere NA, et al. Dermal absorption and distribution of topically dosed jet fuels jet-A, JP-8, and JP-8(100). Toxicol Appl Pharmacol 1999; 160:60-75.
23. Rossi III J, Nordholm AF, Carpenter RL, et al. Effects of repeated exposure of rats to JP-5 or JP-8 jet fuel vapor on neurobehavioral capacity and neurotransmitter levels. J Toxicol Environ Health Part A. 2001; 63:397-428.
24. Sehnert SS, Jiang L, Burdick JF, Risby TH. Breath biomarkers for detection of human liver diseases: preliminary study. Biomarkers 2002; 7:174-87.
25. Siegel S, Castellan Jr NJ. Nonparametric statistics for the behavioral sciences. In: The case of k independent samples. Boston: McGraw-Hill; 1988:213-5.
26. Silkoff PE. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999; 160:2104-17.
27. Taylor JL, O'Hara R, Mumenthaler MS, Yesavage JA. Relationship of CogScreen-AE to flight simulator performance and pilot age. Aviat Space Environ Med 2000; 71:373-80.
28. The Institute of Environmental, and Human Health. 2001. JP-8 Final Risk Assessment. Lubbock, TX: Texas Tech University.
29. Ullrich SE. Dermal application of JP-8 jet fuel induces immune suppression. Toxicol Sci 1999; 52:61-7.